Patterns of concomitant prescription, over-the-counter and natural sleep aid use over a 12-month period: a population based study
| Autor: | Charles M. Morin, Hans Ivers, Simon Beaulieu-Bonneau, Geneviève Morin, Denise C. Jarrin, Janet M Y Cheung |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male Canada Longitudinal study Population Nonprescription Drugs Dysfunctional family Pittsburgh Sleep Quality Index 03 medical and health sciences 0302 clinical medicine Sleep Initiation and Maintenance Disorders Physiology (medical) Insomnia Humans Medicine Longitudinal Studies 030212 general & internal medicine education education.field_of_study business.industry Incidence (epidemiology) Beck Depression Inventory Middle Aged Sleep in non-human animals Prescriptions Insomnia and Psychiatric Disorders Female Neurology (clinical) medicine.symptom Sleep business 030217 neurology & neurosurgery Demography |
| Zdroj: | Sleep |
| ISSN: | 1550-9109 0161-8105 |
| Popis: | Study Objectives Concomitant patterns of sleep aid use may provide insight for understanding the transition to chronic sleep medication use. Therefore, we sought to characterize the trajectories of concomitant natural product (NP), over-the-counter (OTC), and prescribed (Rx) sleep aid use in a population-based sample over 12-months. Methods Self-reported data on the use of NP, OTC, and Rx sleep aids were extracted from a Canadian longitudinal study on the natural history of insomnia (N = 3416, M age = 49.7 ± 14.7 years old; 62% women) at baseline, 6-month, and 12-month. Latent class growth modeling was used to identify latent class trajectories using MPlus Version 7. Participants completed a battery of clinical measures: Ford Insomnia Response to Stress Test, abbreviated Dysfunctional Beliefs and Attitudes about Sleep Scale, Beck Depression Inventory, Insomnia Severity Index and, the Pittsburgh Sleep Quality Index. Associations between class membership and baseline covariates were evaluated. Results Concurrent sleep aid use fell into six distinct latent class trajectories over a 12-month period: Minimal Use (74.5%), Rx-Dominant (11.3%), NP-Dominant (6.3%), OTC-Dominant (4.3%), Rx-NP-Dominant (2.4%), and Rx-OTC-Dominant (1.1%). The three latent classes with prominent prescribed agent use predicted greater incidence of healthcare professional consultations for their sleep (p < 0.05), poorer sleep quality (p < 0.001), elevated dysfunctional sleep beliefs (p < 0.001), and sleep reactivity (p < 0.001). Compared to the other four latent classes, clinical profiles of Rx-NP-dominant and Rx-OTC-dominant groups endorsed greater severity across measures. Conclusions Patterns of sleep aid use may provide insight for identifying individuals who may be vulnerable to inappropriate self-medicating practices. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|